Lv2
118 积分 2022-06-27 加入
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury
20天前
已完结
Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort
1个月前
已完结
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
1个月前
已完结
Cutaneous adverse events caused by immune checkpoint inhibitors
1个月前
已完结
Grade 3 and grade 4 cutaneous toxicities in patients with multiple solid tumour types receiving checkpoint inhibitor therapy: an observational study. The experience of a single large specialist institution
1个月前
已完结
Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patients
1个月前
已完结
Protective effect of bevacizumab against interstitial lung disease in non-squamous non-small-cell lung cancer: a nationwide target trial emulation study
2个月前
已完结
Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer
2个月前
已完结
Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity
2个月前
已完结
The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment
2个月前
已完结
皖公网安备34019202002308
